CFTR and cystic fibrosis: In the past decades, therapy of CF was only symptomatic, but meanwhile, integration of mutation-specific CFTR modulators into clinical practice has achieved treatment of the basic defect of impaired epithelial conductance for chloride and bicarbonate in the majority of all CF patients (1, 2, 43).